Table 1 Correct knowledge related to viral hepatitis transmission among individuals aged between 15 and 64 years according to sex and age in Brazil as measured by the PCAP-2013
Men | Women | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Total | 15–24 years | 25–49 years | 50–64 years | All age groups | p-value | 15–24 years | 25–49 years | 50–64 years | All age groups | p-value | |
Unprotected sexual intercourse | |||||||||||
HBV | 33.1 (30.3–35.9) | 41.6 (33.8–49.9) | 37.3 (32.5–42.4) | 32.7 (26.0–40.2) | 37.5 (33.0–42.3) | 0.17 | 27.9 (22.1–34.5) | 30.1 (26.0–34.7) | 23.9 (18.6–30.1) | 28.6 (25.4–32.0) | 0.27 |
HCV | 34.3 (31.6–37.0) | 33.1 (26.4–40.6) | 36.8 (32.2–41.8) | 30.6 (24.1–37.9) | 34.9 (31.1–38.9) | 0.29 | 27.5 (21.5–34.4) | 38.2 (33.5–43.2) | 25.6 (19.9–32.1) | 33.7 (30.3–37.3) | 0.002 |
HBV/HCV | 17.1 (14.8–19.5) | 17.2 (12.1–23.7) | 19.3 (15.6–23.7) | 18 (13.0–24.3) | 18.6 (15.3–22.4) | 0.72 | 12.8 (8.7–18.4) | 17.7 (14.3–21.8) | 11.6 (7.9–16.6) | 15.6 (13.0–18.6) | 0.06 |
Sharing needles | |||||||||||
HBV | 30.0 (27.5–32.6) | 25.8 (20.4–32.1) | 32 (27.7–36.8) | 29.7 (23.5–36.7) | 30.1 (65.8–34.2) | 0.13 | 29.4 (23.9–35.6) | 29.9 (26.2–33.9) | 30.8 (24.7–37.7) | 29.9 (26.8–33.2) | 0.95 |
HCV | 27.0 (24.7–29.3) | 25.8 (20.3–32.2) | 28.5 (24.4–32.9) | 25.2 (19.7–31.7) | 27.3 (23.9–30.8) | 0.57 | 21.5 (16.8–27.2) | 30.1 (26.5–34.0) | 21.0 (16.3–26.6) | 26.6 (23.9–29.5) | 0.004 |
HBV/HCV | 12.0 (10.3–13.8) | 10.4 (6.8–15.4) | 13.5 (10.9–16.7) | 12.6 (8.4–18.6) | 12.6 (10.3–15.4) | 0.43 | 10.3 (6.9–15.2) | 12.3 (9.9–15.1) | 9.6 (6.6–13.9) | 11.4 (9.5–13.7) | 0.45 |
Sharing manicure/pedicure equipment | |||||||||||
HBV | 30.4 (28.2–32.6) | 30 (23.8–37.0) | 30 (25.8–34.5) | 31.4 (25.6–37.9) | 30.2 (26.6–34.1) | 0.90 | 31.5 (27.1–36.2) | 31.7 (28.5–35.0) | 25.2 (20.9–30.0) | 30.6 (28.0–33.3) | 0.06 |
HCV | 27.2 (25.0–29.4) | 31.1 (24.9–38.0) | 28.8 (25.1–32.8) | 23.4 (18.5–29.0) | 28.4 (25.2–31.8) | 0.15 | 24.2 (20.0–28.9) | 28.0 (24.8–31.4) | 23.2 (19.2–27.8) | 26.3 (23.8–29.0) | 0.12 |
HBV/HCV | 9.7 (8.2–11.2) | 11.3 (7.1–17.6) | 10.5 (8.1–13.6) | 11.8 (8.4–16.3) | 10.9 (8.7–13.6) | 0.85 | 7.7 (5.5–10.9) | 9.4 (7.4–11.7) | 8.2 (5.9–11.2) | 8.8 (7.3–10.6) | 0.52 |
Dental treatment, dialysis or endoscopy | |||||||||||
HBV | 28.0 (25.6–30.4) | 24.7 (19.0–31.5) | 25.4 (21.7–29.5) | 28.9 (22.7–35.9) | 25.9 (22.6–29.5) | 0.56 | 29.0 (23.3–35.4) | 30.1 (26.4–34.2) | 30.2 (24.4–36.6) | 29.9 (26.7–33.3) | 0.93 |
HCV | 27.4 (25.1–30.0) | 27 (21.0–33.9) | 30.3 (26.2–34.8) | 22.7 (17.6–28.8) | 28.2 (24.8–31.2) | 0.10 | 24.6 (19.5–30.6) | 27.9 (24.1–32.1) | 24.5 (19.5–30.3) | 26.6 (23.6–29.9) | 0.42 |
HBV/HCV | 10.6 (9.0–12.2) | 8.6 (5.3–13.6) | 9.1 (7.0–11.9) | 11.6 (7.8–16.9) | 9.5 (7.6–11.8) | 0.53 | 9.5 (6.4–13.9) | 12.5 (9.9–15.7) | 10.9 (7.6–15.5) | 11.6 (9.5–14.1) | 0.37 |
Tattooing or piercing | |||||||||||
HBV | 26.4 (24.0–28.7) | 22.5 (17.3–28.8) | 26.4 (22.5–30.8) | 27.0 (21.0–34.1) | 25.6 (22.3–29.2) | 0.43 | 23.5 (18.6–29.2) | 29.3 (25.6–33.4) | 23.6 (18.7–29.5) | 27.1 (24.1–30.3) | 0.07 |
HCV | 24.5 (27.1–31.8) | 30.3 (23.8–37.7) | 28.9 (24.8–33.3) | 28.3 (22.1–35.5) | 29.1 (25.7–32.9) | 0.89 | 23.6 (18.6–29.4) | 33.4 (29.6–37.4) | 25.1 (20.0–31.1) | 29.8 (26.932.8) | 0.003 |
HBV/HCV | 11.3 (9.6–13.0) | 7.9 (4.9–12.5) | 10.3 (7.8–13.5) | 11.8 (7.9–17.0) | 10.0 (7.9–12.5) | 0.37 | 9.0 (6.0–13.4) | 15.1 (12.3–18.4) | 7.9 (5.3–11.6) | 12.5 (10.4–15.0) | 0.001 |
Denominators | |||||||||||
Unweighted | 12000 | 1503 | 3002 | 1495 | 6000 | 1499 | 3002 | 1499 | 6000 | ||
Weighted | 12000 | 1577 | 3208 | 1081 | 5867 | 1565 | 3362 | 1207 | 6133 | ||